Seattle Cancer Care Alliance, in Seattle, Washington, is part of a dynamic collaboration among three organizations known nationally and internationally for their patient care and research: Fred Hutchinson Cancer Research Center, University of Washington, and Seattle Children's. These three organizations have worked together to support their mission of world class adult and pediatric oncology patient care services, research and education. Please join us and be part of making a difference in the lives of our patients, families, and community!
At Seattle Cancer Care Alliance every patient, every life matters. Our dedicated nurses are a driving force making SCCA a global leader in the prevention, treatment, and cure of cancer. Our nurses rank among leading experts in oncology. Our nurses provide exceptional patient and family-centered care as they coordinate and assist in individualized treatment. They integrate care with support for the research and development of innovative therapies. Embarking with each patient on a journey through cancer treatment and survival, our compassionate nurses walk hand-in-hand with courage and hope with each individual to ensure the best possible patient outcome.
Our nurses are vital to the journey of cancer care. We invite you to explore our career opportunities and apply online for more information.
This position is designed for the new graduate nurse who demonstrates commitment to the vision and mission of SCCA and to the care of cancer patients and their families. In addition, selects ambulatory oncology nursing as their primary clinical nursing practice.
The resident nurse will work closely with a trained preceptor and master skills necessary to provide safe and accurate patient care which include, but not limited to, assessment, treatment administration and evaluation of patient response to treatment. Clinical practice as well as patient/caregiver education will be paramount to this role.
Primary focus during the residency program is to learn about the nursing care of oncology, immunotherapy and bone marrow transplant patients. Training will encompass the understanding of the various oncology diagnosis and treatments plan/protocols, competency in chemotherapy, blood products and other prescribed supportive treatments administration, and evaluation of patient's response to treatment. In addition, in depth understanding of patient and family psych-social needs and the various stages of grief and death and dying will be provided.
This residency has a start date of October 7, 2019.
Performs comprehensive nursing assessment of oncology, immunotherapy and bone marrow transplant patients; this assessment includes review of relevant lab studies, review of systems, assessment of pain, distress and other symptoms.
Ability to operate, or learn to operate, unit-specific processes and equipment as outlined in defined clinical practice standards and competencies. Develop breadth of ability to work with a wide range of staff as part of an interdisciplinary team including physicians, nurses, and ancillary staff.
Provide care adapted to individual patient needs based on SCCA policies/procedures and guidelines, under direct observation of preceptors until competency achieved.
Participate in patient care, consult and collaborate with physicians and other healthcare team members, and implement clinical practice according to institutional standards.
Engage in formal offerings and educational activities during residency that support the clinical functions and duties pertinent to the clinical area in which training is occurring. (i.e. infusion suites, transplant clinics, other clinical care delivery sites within the main campus ambulatory clinic and community sites).
Demonstrate steady progress throughout the residency program and meet milestones and competencies as designed per orientation plan.
Submit weekly self-reflections and participate in the learning discussions.
Maintain open communication with supervisor and preceptors regarding challenges or concerns during the residency program.
Current Washington State Registered Nurse license
Knowledge of human growth and development to modify services to the age and development stage of the patient and awareness of the physical emotional spiritual and social domains of care delivery
Demonstrate knowledge and understanding of patient privacy rights
Current BLS AHA Health Provider Card (or equivalent course, such as by the American Red Cross) and renewal required every two years
Bachelor's in Science Degree in Nursing from an accredited school
Experience in Oncology, bone marrow transplant during student practicum
We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We are proud to be an Equal Opportunity and VEVRAA Employer. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. If due to a disability you need assistance/and or a reasonable accommodation during the application or recruiting process, please send a request to our Employee Services Center at firstname.lastname@example.org or by calling 206-667-4700.
At Fred Hutchinson Cancer Research Center, teams of world-renowned scientists and humanitarians work together to prevent, diagnose and treat cancer, HIV/AIDS and other diseases. Researchers are discovering new ways to detect cancers earlier, improve treatments, and learn how to prevent cancers from growing. Although Fred Hutchinson opened its doors in 1975, its history began about 20 years before that. In 1962 Fred Hutchinson envisioned a center devoted to studying cancer, a disease that took his brother’s life. Today Fred Hutchinson is contributing to the next waves of breakthrough treatments and prevention strategies. Fred Hutchinson collaborates with the Seattle Cancer Alliance, the National Cancer Institute, and the University of Washington.